Spineway マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Stephane Le Roux

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	6yrs
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

CEO（最高経営責任者

Stephane Le Roux

no data

在職期間

€121,331

報酬

Mr. Stephane Le Roux serves as the Chairman, CEO and President of Spineway Société Anonyme.

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Stephane Le Roux	Chairman	no data	€121.33k	データなし
Philippe Laurito	Director & CTO of Spineway Inc.	6yrs	€121.33k	データなし
David Siegrist	Financial Director	no data	データなし	データなし
Agnès Mignani	Human Resources Manager	no data	データなし	データなし
Sandrine Carle	Deputy Chief Executive Officer	less than a year	データなし	データなし
Guillaume Bertet	Controller	no data	データなし	データなし
Mickaël Battisti	Controller	no data	データなし	データなし
Marie-Christelle Desmolles	Controller	no data	データなし	データなし
Jon Luedke	CEO of Spineway Inc.	6yrs	データなし	データなし

6.0yrs

平均在職期間

経験豊富な経営陣: 37S0の経営陣は経験豊富で経験豊富です（平均在職期間は6年）。

Spineway マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Less than half of directors are independent

Less than half of directors are independent

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Less than half of directors are independent

Recent updates

New minor risk - Financial data availability

Less than half of directors are independent

Spineway SA to Report First Half, 2024 Results on Sep 24, 2024

Less than half of directors are independent

Spineway SA, Annual General Meeting, Mar 25, 2024

Full year 2023 earnings released

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway SA to Report Q4, 2023 Results on Feb 07, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Spineway Group Obtains 510(K) Clearance from the US Food and Drug Administration for its VEOS Spinal Fixation System

First half 2023 earnings released

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

New major risk - Shareholder dilution

New major risk - Financial position

Less than half of directors are independent

Spineway SA to Report First Half, 2023 Results on Sep 19, 2023

Spineway SA to Report Fiscal Year 2022 Results on Feb 09, 2023

Less than half of directors are independent

First half 2022 earnings released

Spineway SA (ENXTPA:ALSPW) agreed to acquire Spine Innovations SAS from LBO France.

Spineway SA, Annual General Meeting, May 18, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Spineway Société Anonyme, Annual General Meeting, Mar 23, 2022

Spineway Société Anonyme (ENXTPA:ALSPW) signed a memorandum of understanding to acquire Distimp.

Spineway in Negotiations to Acquire European Spinal Surgery Start-Up

Spineway Société Anonyme Announces Signature of A Partnership with Tsunami Medical

Spineway Société Anonyme, Annual General Meeting, Mar 08, 2021

Full year 2020 earnings released: €0.005 loss per share (vs €0.064 loss in FY 2019)

Spineway Société Anonyme to Report First Half, 2021 Results on Sep 03, 2021

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

マネジメント基準チェック /14